iBio, Inc. (IBIO) Deferred Federal Income Tax Expense (Benefit) USD 2011 - 2023
Historical data
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
iBio, Inc. annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2011 to 2023.
- iBio, Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2023 was -$12.2 M, a 34.3% decline from 2022.
- iBio, Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2022 was -$9.05 M, a 16356% decline from 2021.
- iBio, Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2021 was -$55 K, a 96.5% increase from 2020.
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Annual Growth (%)